Viewing Study NCT02105350


Ignite Creation Date: 2025-12-24 @ 4:46 PM
Ignite Modification Date: 2026-02-25 @ 7:27 PM
Study NCT ID: NCT02105350
Status: WITHDRAWN
Last Update Posted: 2018-02-19
First Post: 2014-04-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer
Sponsor: University Health Network, Toronto
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module